Abstract:Objective :— This study is to explore the effect of valsartan-eluting stents on neointima formation after stenting and to elucidate possible mechanisms how locally used valsartan prevents in-stent restenosis (ISR). METHOD: valsartan- and carriereluting stents were manufactured by using multi-layer-coated technology. Bare stents, carrier-eluting stents and valsartan– eluting stents were implanted into the abdominal aortas of the rabbits respectively. Quantitative angiography (QA) before, immediately after and 3 months after stent implantation were compared between the groups of bare (n=8), carrier-eluting (n=8) and valsartan-eluting stent (n=10), which allows the comparison of vascular diameters of aortas as well as indices of vascular neointimal formation, i.e. luminal area (LA), neointimal area (NIA), inner elastic membrane luminal area (IELA) and the maximal inner-membrane thickness (MIT) in 15 rabbits. α-Actin protein expression were detected by Envision two-step immunohistochemistry. Mean positive indices (MPI) of the above protein were analyzed semi-quantatively by IMS(Information Management System) cell image analysis system. MPI=positive area×OD (optical density). Collagen deposition in neointima was observed through MASSON stain among the three groups. Result:— the mean aortic diameters were similar in the three groups:bare stents group(n=8), carrier-eluting stents group(n=8) and valsartan eluting stents group(n=10) measured by QA at different time. A larger luminal area and a less neointimal hyperplasia in valsartan eluting-stents group was found compared with the other two groups. The mean luminal areas were 4345548±125822um2; 4302061±167952 um2; 5016269±207934um2 respectively. The mean neointimal areas were 1119635±163503um2; 1135636±136555um2; 441577±74099um2 and the mean maximal inner-membrane thickness were 210±30um;192±21um; 116±12um respectively. α-Actin protein expression was significantly lower in neointima of valsartan eluting-stents group than the other two groups. Through MASSON stain we found that Collagen was much richer in neointima of bare stents group and carrier-eluting stents group than valsartan eluting-stents group. Conclusion:— Valsartan eluting-stents inhibited neointimal hyperplasia after stenting by decreasing collagen deposition and smooth muscle cell proliferation. Therefore it would be potentially effective in preventing in-stent restenosis. Abbreviations:— Quantitative angiography (QA), luminal area (LA), neointimal area (NIA), inner elastic membrane luminal area (IELA), the maximal inner-membrane thickness (MIT), Mean positive indices (MPI), optical density (OD), Drugeluting stents (DES), in-stent restenosis(ISR), percutaneous transluminal coronary angioplasty (PTCA), angiotensin α type 2 receptor (AT2).

The experimental study of xue guan tong (血맜通) on preventing restenosis after percutaneous transluminal angioplasty

The Effect of Testosterone Undecanoate on Intima Restoration of Iliac Artery After Injury in Male Rabbit

[Effect of Testosterone on Neointimal Proliferation and Blood Lipids after Balloon-Induced Aorta Injury in Rabbits].

[Effects of Xuefu Zhuyu Granule and Danlou Tablet on Anti-atherosclerosis Rats and Potential Mechanisms]

Extract from Tripterygium Hypoglaucum Hutch Inhibits Neointimal Formation of Rabbit Carotid Arteries after Balloon Angioplasty

To Compare the Curative Effect of the Antiplatelet Therapy Between Puerarin Injection and Xueshuantong Injection Among Patients with Unstable Angina After Percutaneous Coronary Stent Implantation

Xueshuantong Improves Cerebral Blood Perfusion in Elderly Patients with Lacunar Infarction.

Effects of Probucol and Losartan on the Expression of Growth Factors after Balloon Angioplasty

[To Study the Effects of Local Co-Transfection Vascular Endothelial Growth Factor165 and Tissue-Type Plasminogen Activator Genes on Inhibiting Intimal Hyperplasia after Operation Injury Artery in Rabbits].

[Effects of Platelet Derived Growth Factor Antisense Oligodeoxynucleotides and Tissue-Type Plasminogen Activator Gene Transfection on Inhibition of Intimal Proliferation].

Influence of Valsartan-Eluting Stent on Neointima Formation

Protective Effects of Tongxinluo, Carvedilol and Valsartan on Microvascular Endothelial Function and Integrity after Late Reperfused AMI in Rabbits

Effect of Xianhua Huogudan Granules on Hemorrheology and Blood Lipid of Steroid-Induced Avascular Necrosis of Femoral Head

Effects of Certain Vasoactive Peptides on Pathogenesis of Vascular Restenosis.

Association Between Stent Implantation and Progression of Nontarget Lesions in a Rabbit Model of Atherosclerosis

Effect of Gelanxinning in NSTE-ACS Patients Undergoing Percutaneous Coronary Intervention

[A Clinical Trial of Using Antiplatelet Therapy to Prevent Restenosis Following Peripheral Artery Angioplasty and Stenting].

Clinical Study of Xiongshao Capsule in Preventing Restenosis after Coronary Interventional Treatment

Study of Component Compatibility from Qixue Bingzhi Recipe in Preventing and Treating Rabbit Arteriosclerosis

Cardioprotective Effects of Guanxinshutong (GXST) Against Myocardial Ischemia/reperfusion Injury in Rats

[Study on inhibiting the intimal hyperplasia after rabbit artery injury by local transfection of tissue-type plasminogen activator gene].